UNSPSC 51351516: Anagestone

This classification denotes a therapeutic progestin with the molecular formula C22H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8FB38IU3G, chemically known as 17-hydroxy-6.alpha.-methylpregn-4-en-20-one but generally known as anagestone, which bears US NIH Compound Identifier 160650. European Medicines Agency schedules Anagestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05498MIG. Most nations schedule anagestone under HS 29372300 and SITC 54153.

As of Q4 2014, ANAGESTONE remains the US FDA Preferred Term for this commodity. Anagestone bears US NLM identifiers UMLS ID C0051808 and NCI Concept Code C79752. SMILES: CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CCCC4)C.

I cannot write a meaningful summary of UNSPSC 51351516 Anagestone because the source provides no information about what state and local governments actually buy under this code, no recent opportunities, no issuing bodies, and no geographic activity. The source lists only the code number and name without supporting detail.

To produce a usable summary, I would need access to recent state and local contract opportunities tagged under this Commodity code — solicitations from state departments, counties, cities, school districts, or transit authorities that show what work is actually being procured, where, and when.